Activation of the NRF2 antioxidant program sensitizes tumors to G6PD inhibition

Hongyu Ding, Zihong Chen, Katherine Wu, Shih Ming Huang, Warren Wu, Sarah E. LeBoeuf, Ray Pillai, Joshua D. Rabinowitz, Thales Papagiannakopoulos

Science Advances · 2021 · 91 citations · 64 references

DOIFull text

Open access

Concepts

Abstract

mutant tumor growth, and this suppression was further augmented by TCA depletion by glutaminase inhibition. Thus, G6PD inhibition–induced TCA depletion is a therapeutic vulnerability of NRF2-activated cancer.

References

64